UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 3.449

Sortiert nach

Prognostic value of KRAS G12V mutation in lung adenocarcinoma stratified by stages and radiological features

The Journal of thoracic and cardiovascular surgery, 2024-03

2024

Link zum Volltext

Verfügbarkeit prüfen

KRAS G12C mutated advanced non-small cell lung cancer (NSCLC): Characteristics, treatment patterns and overall survival from a Danish nationwide observational register study

Lung cancer (Amsterdam, Netherlands), 2023-04, Vol.178, p.172-182

2023

Link zum Volltext

Verfügbarkeit prüfen

KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness in Synchronous Metastatic Colorectal Cancer (mCRC): Retrospective Research

OncoTargets and therapy, 2020-01, Vol.13, p.12601-12613

2020

Link zum Volltext

Verfügbarkeit prüfen

Real world outcomes in KRAS G12C mutation positive non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2020-08, Vol.146, p.310-317

2020

Link zum Volltext

Verfügbarkeit prüfen

KRAS -G12C Mutation in One Real-Life and Three Population-Based Nordic Cohorts of Metastatic Colorectal Cancer

Frontiers in oncology, 2022-02, Vol.12, p.826073-826073

2022

Link zum Volltext

Verfügbarkeit prüfen

Subtyping of advanced lung cancer based on PD-L1 expression, tumor histopathology and mutation burden (EGFR and KRAS): a study from North India

Monaldi archives for chest disease, 2023-02, Vol.93 (4)

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical characteristics and prognostic value of the KRAS G12C mutation in Chinese non-small cell lung cancer patients

Biomarker research, 2020-06, Vol.8 (1), p.22-22, Article 22

2020

Link zum Volltext

Verfügbarkeit prüfen

Second‐Line Therapy for Advanced NSCLC

The oncologist (Dayton, Ohio), 2013-08, Vol.18 (8), p.947-953

2013

Link zum Volltext

Verfügbarkeit prüfen

Synergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS‐mutant cancer

EMBO molecular medicine, 2021-09, Vol.13 (9), p.e13193-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Multiplex detection of KRAS mutations by a matrix-assisted laser desorption/ionization-time of flight mass spectrometry assay

Clinical biochemistry, 2014-08, Vol.47 (12), p.1091-1097

2014

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC)

Journal of thoracic oncology, 2019-06, Vol.14 (6), p.1095-1101

2019

Link zum Volltext

Verfügbarkeit prüfen

Molecular epidemiology and diagnostics of KRAS mutations in human cancer

Cancer and metastasis reviews, 2020-12, Vol.39 (4), p.1029-1038

2020

Link zum Volltext

Verfügbarkeit prüfen

CHNet: A multi-task global-local Collaborative Hybrid Network for KRAS mutation status prediction in colorectal cancer

Artificial intelligence in medicine, 2024-07, p.102931, Article 102931

2024

Link zum Volltext

Verfügbarkeit prüfen

KRAS G12D mutation eliminates reactive oxygen species through the Nrf2/CSE/H 2S axis and contributes to pancreatic cancer growth

Acta biochimica et biophysica Sinica, 2022-11, Vol.54 (11), p.1731-1739

2022

Link zum Volltext

Verfügbarkeit prüfen

Mutation analysis of papillary tubal hyperplasia associated with ovarian atypical proliferative serous tumor and low-grade serous carcinoma

American journal of obstetrics and gynecology, 2013-08, Vol.209 (2), p.e6-e8

2013

Link zum Volltext

Verfügbarkeit prüfen

Performance of a novel KRAS mutation assay for formalin-fixed paraffin embedded tissues of colorectal cancer

SpringerPlus, 2015-01, Vol.4 (1), p.7-7, Article 7

2015

Link zum Volltext

Verfügbarkeit prüfen

BMP4 and PHLDA1 are plausible drug-targetable candidate genes for KRAS G12A-, G12D-, and G12V-driven colorectal cancer

Molecular and cellular biochemistry, 2021-09, Vol.476 (9), p.3469-3482

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non–Small Cell Lung Cancer

Journal of thoracic oncology, 2018-04, Vol.13 (4), p.576-584

2018

Link zum Volltext

Verfügbarkeit prüfen

High Glucose Triggers Nucleotide Imbalance through O-GlcNAcylation of Key Enzymes and Induces KRAS Mutation in Pancreatic Cells

Cell metabolism, 2019-06, Vol.29 (6), p.1334-1349.e10

2019

Link zum Volltext

Verfügbarkeit prüfen

Innovative PNA-LB mediated allele-specific LAMP for KRAS mutation profiling on a compact lab-on-a-disc device

Talanta (Oxford), 2024-08, Vol.276, p.126224, Article 126224

2024

Link zum Volltext

Verfügbarkeit prüfen

PDP1 promotes KRAS mutant colorectal cancer progression by serving as a scaffold for BRAF and MEK1

Cancer letters, 2024-08, Vol.597, p.217007, Article 217007

2024

Link zum Volltext

Verfügbarkeit prüfen

Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer

Proceedings of the National Academy of Sciences - PNAS, 2016-09, Vol.113 (36), p.E5328-E5336

2016

Link zum Volltext

Verfügbarkeit prüfen

The relationship between different subtypes of KRAS and PD-L1 & tumor mutation burden (TMB) based on next-generation sequencing (NGS) detection in Chinese lung cancer patients

Translational lung cancer research, 2022-02, Vol.11 (2), p.213-223

2022

Link zum Volltext

Verfügbarkeit prüfen

Exploration of efficacy of different therapy regimens for advanced NSCLC patients with KRAS mutation in the first-line treatment

Clinical & translational oncology, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 3.449

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.132)
Mit Volltextzugriff
(3.269)

Publikationsform

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.154)
Life Sciences & Biomedicine
(3.059)
Mutation
(2.589)
Humans
(2.305)
Kras
(2.174)
Oncology
(1.713)
Female
(1.223)
Male
(1.087)
Tumors
(1.061)
Proto-Oncogene Proteins P21 - Genetics
(1.054)
Colorectal Cancer
(994)
Middle Aged
(970)
Aged
(883)
Ras Proteins - Genetics
(757)
Proto-Oncogene Proteins P21
(699)
Proto-Oncogene Proteins - Genetics
(697)
Adult
(678)
Colorectal Neoplasms - Genetics
(675)
Cancer
(608)
Kras Mutation
(605)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancers
(123)
International Journal Of Molecular Sciences
(80)
Lung Cancer
(77)
Bmc Cancer
(71)
Oncotarget
(66)
Journal Of Thoracic Oncology
(63)
International Journal Of Cancer
(54)
Anticancer Research
(53)
Human Pathology
(52)
Frontiers In Oncology
(47)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(39)

Menü

Weitere Dienste

Einstellungen

Prognostic value of KRAS G12V mutation in lung adenocarcinoma stratified by stages and radiological features

KRAS G12C mutated advanced non-small cell lung cancer (NSCLC): Characteristics, treatment patterns and overall survival from a Danish nationwide observational register study

KRAS G12C-mutated advanced non-small cell lung cancer: A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness in Synchronous Metastatic Colorectal Cancer (mCRC): Retrospective Research

Real world outcomes in KRAS G12C mutation positive non-small cell lung cancer

KRAS -G12C Mutation in One Real-Life and Three Population-Based Nordic Cohorts of Metastatic Colorectal Cancer

Subtyping of advanced lung cancer based on PD-L1 expression, tumor histopathology and mutation burden (EGFR and KRAS): a study from North India

Clinical characteristics and prognostic value of the KRAS G12C mutation in Chinese non-small cell lung cancer patients

Second‐Line Therapy for Advanced NSCLC

Synergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS‐mutant cancer

Multiplex detection of KRAS mutations by a matrix-assisted laser desorption/ionization-time of flight mass spectrometry assay

Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC)

Molecular epidemiology and diagnostics of KRAS mutations in human cancer

CHNet: A multi-task global-local Collaborative Hybrid Network for KRAS mutation status prediction in colorectal cancer

KRAS G12D mutation eliminates reactive oxygen species through the Nrf2/CSE/H 2S axis and contributes to pancreatic cancer growth

Mutation analysis of papillary tubal hyperplasia associated with ovarian atypical proliferative serous tumor and low-grade serous carcinoma

Performance of a novel KRAS mutation assay for formalin-fixed paraffin embedded tissues of colorectal cancer

BMP4 and PHLDA1 are plausible drug-targetable candidate genes for KRAS G12A-, G12D-, and G12V-driven colorectal cancer

Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non–Small Cell Lung Cancer

High Glucose Triggers Nucleotide Imbalance through O-GlcNAcylation of Key Enzymes and Induces KRAS Mutation in Pancreatic Cells

Innovative PNA-LB mediated allele-specific LAMP for KRAS mutation profiling on a compact lab-on-a-disc device

PDP1 promotes KRAS mutant colorectal cancer progression by serving as a scaffold for BRAF and MEK1

Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer

The relationship between different subtypes of KRAS and PD-L1 & tumor mutation burden (TMB) based on next-generation sequencing (NGS) detection in Chinese lung cancer patients

Exploration of efficacy of different therapy regimens for advanced NSCLC patients with KRAS mutation in the first-line treatment

Suchergebnisse filtern